tiprankstipranks
Advertisement
Advertisement
Filippo Falorni Reiterates Hold on Kenvue, Keeps Price Target Unchanged at $19 Amid Renewed Tylenol Litigation Risks
PremiumRatingsFilippo Falorni Reiterates Hold on Kenvue, Keeps Price Target Unchanged at $19 Amid Renewed Tylenol Litigation Risks
23d ago
Appeals court revives autism suits against Kenvue’s Tylenol, Bloomberg says
Premium
The Fly
Appeals court revives autism suits against Kenvue’s Tylenol, Bloomberg says
24d ago
Appeals court rules Kenvue must face Tylenol autism claims, Bloomberg says
Premium
The Fly
Appeals court rules Kenvue must face Tylenol autism claims, Bloomberg says
24d ago
Starboard takes new stakes in Lamb Weston and CarMax, exits Autodesk position
PremiumThe FlyStarboard takes new stakes in Lamb Weston and CarMax, exits Autodesk position
3M ago
Kenvue reports Q1 adjusted EPS 32c, consensus 26c
Premium
The Fly
Kenvue reports Q1 adjusted EPS 32c, consensus 26c
3M ago
Notable companies reporting before tomorrow’s open
Premium
The Fly
Notable companies reporting before tomorrow’s open
3M ago
Kenvue price target lowered to $18 from $19 at UBS
PremiumThe FlyKenvue price target lowered to $18 from $19 at UBS
4M ago
Kenvue price target raised to $19 from $18 at Barclays
Premium
The Fly
Kenvue price target raised to $19 from $18 at Barclays
5M ago
Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports
Premium
The Fly
Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100